ArticleLancet (London, England)2016
Gemcitabine-resistant pancreatic cancer: a second-line option.
Helmut Oettle et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleLancet (London, England)2016
Helmut Oettle et al.PubMed ↗Publisher ↗
No numbers read from the abstract.